First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
As global markets grapple with tariff uncertainties and mixed economic signals, investors are seeking stability amidst the volatility. With U.S. stocks ending the week lower and manufacturing showing ...
Detailed price information for Fox Factory Corp (FOXF-Q) from The Globe and Mail including charting and trades.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Sweden-listed Hoegh Autoliners ASA posted the largest decline among large stocks during the session, declining 9.7%, followed by Norway-listed Hoegh Autoliners ASA shares, which fell 9.4%. Shares of ...
Stocks in the Nordic region increased Thursday, with the OMX Nordic 40 Index rising 0.3%. Sinch AB was the biggest leader among large stocks during the session, surging 17.4%, and Storskogen Group AB ...
Euronext N.V. reports strong Q4 2024 earnings with double-digit growth, strategic acquisitions, and innovation.
ProShares, a premier provider of ETFs, today commemorates the 15-year anniversary of ProShares UltraPro QQQ (TQQQ), which has grown to become the world's largest leveraged ETF since its inception on ...
A year characterized by several challenges but with clear signs of improvements in a market that remains slightly cautious The final quarter of the year confirms the clear signs of improvements we hav ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...